Urgent need for a new staging system in advanced colorectal cancer.
暂无分享,去创建一个
M. Choti | E. Van Cutsem | B. Nordlinger | T. Gruenberger | M. D'Angelica | F. Giuliante | J. Figueras | G. Poston | J. Chiang | A. Sobrero | A. Bilchik | R. Adam | G. Nuzzo | J. Gigot
[1] Daniel J Sargent,et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] M. Ychou,et al. Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases , 2008, Cancer Chemotherapy and Pharmacology.
[3] A. Carrato,et al. Colorectal cancer metastasis resectability after treatment with the combination of oxaliplatin, irinotecan and 5-fluorouracil. Final results of a phase II study , 2008, Acta oncologica.
[4] E. Van Cutsem,et al. Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Yuman Fong,et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] M. Ducreux,et al. Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] F. Giuliante,et al. Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases , 2007, British Journal of Cancer.
[8] A. Carrato,et al. Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group. , 2007, European journal of cancer.
[9] J. Figueras,et al. Surgical treatment of liver metastases from colorectal carcinoma in elderly patients. When is it worthwhile? , 2007, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
[10] J. Figueras,et al. Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[11] L. Crinò,et al. Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] T. Serrano,et al. Surgical Resection of Colorectal Liver Metastases in Patients with Expanded Indications: A Single-Center Experience with 501 Patients , 2007, Diseases of the colon and rectum.
[13] M. Ychou,et al. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. , 2006, European journal of cancer.
[14] Catherine Julié,et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] D. Berger,et al. RFA for liver tumors: does it really work? , 2006, The oncologist.
[16] J. Vauthey,et al. Downstaging or downsizing: time for a new staging system in advanced colorectal cancer? , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] M. Basso,et al. Long-term follow-up of colorectal cancer (CRC) patients treated with neoadjuvant chemotherapy with irinotecan and fluorouracil plus folinic acid (5-FU/FA) for unresectable liver metastases. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] T. Seufferlein,et al. Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[19] D. Sargent,et al. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] E. Beckner,et al. STANDING ON THE SHOULDERS OF GIANTS , 2005 .
[21] S. Curley,et al. OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] J. Pignon,et al. Hepatic and Extrahepatic Colorectal Metastases: When Resectable, Their Localization Does Not Matter, But Their Total Number Has a Prognostic Effect , 2005, Annals of Surgical Oncology.
[23] C. Köhne,et al. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[24] F. Lévi,et al. Three-drug chronotherapy via hepatic artery as salvage treatment for patients with liver-only metastases from colorectal cancer , 2005 .
[25] H. Hayat,et al. Alternating hepatic artery chronotherapy with CPT-11 and systemic chronotherapy with 5-FU/FA + carboplatin for metastatic colorectal cancer confined to the liver: A phase II study , 2005 .
[26] F. Lordick,et al. A phase I/II study of cetuximab in combination with 5-fluorouracil (5-FU)/folinic acid (FA) plus weekly oxaliplatin (L-OHP) (FUFOX) in the first-line treatment of patients with metastatic colorectal cancer (mCRC) expressing epidermal growth factor receptor (EGFR). Preliminary results , 2005 .
[27] A. Carrato,et al. Resectability of liver metastases (LM) in patients with advanced colorectal cancer (ACRA) after treatment with the combination of oxaliplatin (OXA), irinotecan (IRI) and 5FU. Final results of a phase II study , 2005 .
[28] L. Rimassa,et al. Definitive results of hybrid chemotherapy with intravenous (iv) oxaliplatin (OXA) and folinic acid (FA), and intra-hepatic infusion (HAI) of 5-fluorouracil (5-FU) in patients with colorectal liver metastases , 2005 .
[29] P. Ballardini,et al. Phase II randomized trial on protracted 5-fluorouracil infusion plus oxaliplatin (FOX) versus capecitabine plus oxaliplatin (XELOX) as first-line treatment in advanced colorectal cancer (ACRC): Preliminary results of the Italian FOCA Study , 2005 .
[30] W. Hiddemann,et al. Hepatic artery infusion of 5-fluorouracil, folinic acid plus oxaliplatin for liver metastasis from colorectal cancer. Final analysis of a phase I/II studay , 2005 .
[31] R. Stupp,et al. Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[32] M. Weiser,et al. An increasingly common challenge: management of the complete responder with multi-focal metastatic colorectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] G. Poston. Radiofrequency ablation of colorectal liver metastases: where are we really going? , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] F. Lévi,et al. Tumor Progression While on Chemotherapy: A Contraindication to Liver Resection for Multiple Colorectal Metastases? , 2004, Annals of surgery.
[35] Bernard Paule,et al. Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy: A Model to Predict Long-term Survival , 2004, Annals of surgery.
[36] J. García-Foncillas,et al. Triplet therapy with oxaliplatin, irinotecan, 5-fluorouracil and folinic acid within a combined modality approach in patients with liver metastases from colorectal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] R. Advani,et al. A phase II study of gefitinib in combination with FOLFOX-4 (IFOX) in patients with metastatic colorectal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] W. Scheithauer,et al. Neoadjuvant chemotherapy for resectable colorectal cancer liver metastases: Impact on magnitude of liver resection and survival , 2004 .
[39] L. Schwartz,et al. Liver resection after hepatic arterial infusion (HAI) plus systemic oxaliplatin (Oxal) combinations in pretreated patients with extensive unresectable colorectal liver metastases , 2004 .
[40] P. Hérait,et al. Dose-finding study of weekly 24-h continuous infusion of 5-fluorouracil associated with alternating oxaliplatin or irinotecan in advanced colorectal cancer patients. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[41] Kenneth Hess,et al. Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases , 2004, Annals of surgery.
[42] D. Sargent,et al. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] M. Ducreux,et al. Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy , 2004, Journal of surgical oncology.
[44] Neal J Meropol,et al. Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[45] J. Pignon,et al. Results of R0 Resection for Colorectal Liver Metastases Associated With Extrahepatic Disease , 2004, Annals of Surgical Oncology.
[46] C. Tournigand,et al. FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] Tomoyuki Kato,et al. Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer , 2004, The British journal of surgery.
[48] L. Zelek,et al. Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology trial). , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[49] L. Chiche. [When is first-line resection of hepatic metastasis indicated?]. , 2003, Gastroenterologie clinique et biologique.
[50] M. Rivoire,et al. Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma , 2002, Cancer.
[51] M. Yasuno,et al. Evaluation of Aggressively Treated Patients With Unresectable Multiple Liver Metastases From Colorectal Cancer , 2002, Diseases of the colon and rectum.
[52] Michael A. Choti,et al. Trends in Long-Term Survival Following Liver Resection for Hepatic Colorectal Metastases , 2002, Annals of surgery.
[53] U. Baum,et al. Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[54] F. Lévi,et al. Five-Year Survival Following Hepatic Resection After Neoadjuvant Therapy for Nonresectable Colorectal [Liver] Metastases , 2001, Annals of Surgical Oncology.
[55] W. Lees,et al. Neo-adjuvant therapy improves resectability rates for colorectal liver metastases. , 2001, Annals of the Royal College of Surgeons of England.
[56] D. Khayat,et al. Prospective Phase II Trial of Irinotecan, 5-Fluorouracil, and Leucovorin in Combination as Salvage Therapy for Advanced Colorectal Cancer , 2001 .
[57] L H Blumgart,et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. , 1999, Annals of surgery.
[58] J. Ledermann,et al. Neoadjuvant therapy improves resectability rates for colorectal liver metastases , 1999 .
[59] F. Lévi,et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[60] T. Takayama,et al. A pilot study of multimodality therapy for initially unresectable liver metastases from colorectal carcinoma: hepatic resection after hepatic arterial infusion chemotherapy and portal embolization. , 1997, Japanese journal of clinical oncology.
[61] F. Lévi,et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. , 1996, Annals of surgery.
[62] B. Nordlinger,et al. Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients , 1996, Cancer.
[63] W. Johnson,et al. Lung recurrence after curative surgery for colorectal cancer , 1987, Diseases of the colon and rectum.
[64] F. A. Coller,et al. THE PROGNOSTIC SIGNIFICANCE OF DIRECT EXTENSION OF CARCINOMA OF THE COLON AND RECTUM , 1954, Annals of surgery.
[65] C. Dukes. The Surgical Pathology of Rectal Cancer , 1949, American journal of surgery.
[66] Ma Dong,et al. Bevacizumab plus Irinotecan,Fluorouracil,and Leucovorin for Metastatic Colorectal Cancer , 2006 .
[67] Z. Hua. Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer , 2006 .
[68] P. Rougier,et al. Cetuximab in combination with irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFIRI) in the first-line treatment of metastatic colorectal cancer (mCRC) , 2005 .
[69] T. Mok,et al. Liver resection after irinotecan, 5-fluorouracil, and folinic acid for patients with unresectable colorectal liver metastases , 2005, Medical oncology.
[70] Richard Stang,et al. Resection of colorectal liver metastases , 1997, Journal of Gastrointestinal Surgery.
[71] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[72] C. Balch,et al. AJCC Cancer Staging Manual. 6th ed , 2002 .
[73] D. Khayat,et al. Prospective phase II trial of iriontecan, 5-fluorouracil, and leucovorin in combination as salvage therapy for advanced colorectal cancer. , 2001, American journal of clinical oncology.
[74] L. Ellis,et al. Surgery After Downstaging of Unresectable Hepatic Tumors With Intra-Arterial Chemotherapy , 2000, Annals of Surgical Oncology.
[75] K. Hughes. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases. , 1988, Surgery.
[76] Peter Schlag,et al. Resection of the liver for colorectal carcinoma metastases , 1988, Diseases of the colon and rectum.